ZIOPHARM ONCOLOGY INC 4
4 · ZIOPHARM ONCOLOGY INC · Filed Jun 14, 2017
Insider Transaction Report
Form 4
BRENNAN MURRAY
Director
Transactions
- Exercise/Conversion
Common Stock
2017-06-12$4.85/sh+15,000$72,750→ 68,114 total - Tax Payment
Common Stock
2017-06-12$5.47/sh−13,300$72,751→ 54,814 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-06-12−15,000→ 0 totalExercise: $4.85Exp: 2017-06-18→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]Represents shares withheld to pay exercise price.
- [F2]5,000 shares vested and became exercisable on each of 6/18/08, 6/18/09 and 6/18/10.